Key Stats
Key stats represent essential financial metrics and indicators used to evaluate a company's performance and potential investment opportunities.
Stock Score/grades
The Stock Score/Grades evaluate bankruptcy risk and assess the financial strength and fundamental health of a company
- Altman Z Score 14.51
- Piotroski Score 6.00
- Grade Outperform
- Symbol (TECH)
- Company Bio-Techne Corporation
- Price $74.76
- Changes Percentage (-1.5%)
- Change -$1.14
- Day Low $74.76
- Day High $74.91
- Year High $85.57
Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells life science reagents, instruments, and services for the research and clinical diagnostic markets worldwide. The company operates through two segments, Protein Sciences, and Diagnostics and Genomics. The Protein Sciences segment develops and manufactures biological reagents used in various aspects of life science research, diagnostics, and cell and gene therapy, such as cytokines and growth factors, antibodies, small molecules, tissue culture sera, and cell selection technologies. This segment also offers proteomic analytical tools for automated western blot and multiplexed ELISA workflow consists of manual and automated protein analysis instruments and immunoassays for use in quantifying proteins in various biological fluids. The Diagnostics and Genomics segment develops and manufactures diagnostic products, including controls, calibrators, and diagnostic assays for regulated diagnostics market, exosome-based molecular diagnostic assays, advanced tissue-based in-situ hybridization assays for spatial genomic and tissue biopsy analysis, and genetic and oncology kits for research and clinical applications; and sells products for genetic carrier screening, oncology diagnostics, molecular controls, and research, as well as instruments and process control products for hematology, blood chemistry and gases, and coagulation controls and reagents used in various diagnostic applications. It offers its products under R&D Systems, Tocris Biosciences, Novus Biologicals, ProteinSimple, Advanced Cell Diagnostics, Exosome Diagnostics, and Asuragen brands. The company was formerly known as Techne Corporation and changed its name to Bio-Techne Corporation in November 2014. Bio-Techne Corporation was founded in 1976 and is headquartered in Minneapolis, Minnesota.
- Last Earnings 10/30/2024
- Ex-Dividend for 5/16 Dividend 11/08/2024
- Dividend Payable 11/22/2024
- Today N/A
- Next Earnings (Estimated) 01/30/2025
- Fiscal Year End N/A
- Average Stock Price Target $90.75
- High Stock Price Target $105.00
- Low Stock Price Target $80.00
- Potential Upside/Downside N/A
- Consensus Rating Sell
- Rating Score (0-4) N/A
- Research Coverage N/A
- EPS (Most Recent Fiscal Year) $1.25
- Trailing P/E Ratio 62.1
- Forward P/E Ratio 62.1
- P/E Growth 62.1
- Net Income $168.11 M
Income Statement
Quarterly
Annual
Latest News of TECH
The Latest News section aggregates recent news posts from various news outlets, offering a comprehensive overview of the most recent developments related to the topic.
-
Institutional investors may overlook Qifu Technology, Inc.'s (NASDAQ:QFIN) recent US$317m market cap drop as long-term gains remain positive
Qifu Technology, Inc. has 11 investors holding 51% majority stake. Institutional investors own 69% of shares, with hedge funds and top individual shareholders also holding significant stakes. A divers...
By Yahoo! Finance | 3 hours ago -
West Georgia set for road matchup with the Georgia Tech Yellow Jackets
Georgia Tech Yellow Jackets, with an 8-7 home record and 14-18 overall, gave up 75.2 points per game and committed 16.6 fouls last season. West Georgia did not compete in Division I....
By AP NEWS | 5 hours ago -
Texas Tech opens season at home against Bethune-Cookman
Texas Tech Red Raiders kick off the season at home against Bethune-Cookman Wildcats. Texas Tech had a strong home record last season while Bethune-Cookman focused on scoring in various ways during the...
By AP NEWS | 5 hours ago
